Mcfarlane Neil F. Insider Trades

Insider Trading History

Track insider trading activity for Mcfarlane Neil F.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $2.7M 241,516 shares
Last Trade
Oct 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$551k 50,000 shares
$11.01
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $2.48M 222,016 shares
Last Trade
Oct 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$211k 19,500 shares
$10.82
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $1.12M 100,000 shares
Last Trade
Oct 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$551k 50,000 shares
$11.01
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $2.14M 191,516 shares
Last Trade
Feb 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$246k 30,544 shares
$8.05
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $2.48M 222,060 shares
Last Trade
Feb 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$482k 61,273 shares
$7.86
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $2.51M 225,000 shares
Last Trade
Feb 07, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.75M 225,000 shares
$7.77
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $3.16M 283,333 shares
Last Trade
Jan 31, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.83M 233,333 shares
$7.84
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $5.21M 466,667 shares
Last Trade
Jan 31, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.83M 233,333 shares
$7.84
$11.17
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.61M 49,365 shares
Last Trade
May 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$259k 7,693 shares
$33.67
$32.69
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $7.82M 700,000 shares
Last Trade
Jan 31, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.05M 700,000 shares
$5.79
$11.17
Zevra Therapeutics
Zevra Therapeutics ZVRA
President And CEO
Holding Value $2.23M 200,000 shares
Last Trade
Oct 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.85M 600,000 shares
$4.75
$11.17
Zevra Therapeutics
Zevra Therapeutics KMPH
President And CEO
Holding Value $3.49M 600,000 shares
Last Trade
Oct 10, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.49M 600,000 shares
$5.81
$5.81
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.36M 41,672 shares
Last Trade
May 18, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$221k 9,792 shares
$22.53
$32.69
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $1.04M 31,880 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$224k 14,035 shares
$15.98
$32.69
Collegium Pharmaceutical
Collegium Pharmaceutical COLL
Director
Holding Value $583k 17,845 shares
Last Trade
Apr 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$373k 17,845 shares
$20.88
$32.69
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Executive Officer
Holding Value $4.93M 600,000 shares
Last Trade
Nov 24, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$617k 75,000 shares
$8.22
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Nov 24, 2021 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$1.64M 200,000 shares
$8.22
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
Nov 24, 2021 Sale (Tender)Reported as Tender on SEC Form 4.
$4.93M 600,000 shares
$8.22
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Executive Officer
Holding Value $4.32M 525,000 shares
Last Trade
Mar 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 300,000 shares
$5.26
$8.22
Adamas Pharmaceuticals
Adamas Pharmaceuticals ADMS
Chief Executive Officer
Holding Value $1.03M 125,000 shares
Last Trade
Sep 16, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.56M 250,000 shares
$6.25
$8.22

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up